NYSE:CTST - CannTrust Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started C$5.78 +0.09 (+1.58 %) (As of 05/24/2019 11:19 AM ET)Previous CloseC$5.69Today's RangeC$5.71 - C$5.9052-Week RangeC$4.35 - C$11.97Volume38,723 shsAverage Volume1.87 million shsMarket CapitalizationC$610.59 millionP/E RatioN/ADividend YieldN/ABeta4.05 ProfileAnalyst RatingsChartEarningsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email CannTrust Holdings Inc. produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc. was incorporated in 2015 and is headquartered in Vaughan, Canada. Receive CTST News and Ratings via Email Sign-up to receive the latest news and ratings for CTST and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNYSE:CTST Previous Symbol CUSIPN/A CIKN/A Webhttp://canntrust.ca/ Phone64-7872-2300Debt Debt-to-Equity Ratio0.01 Current Ratio5.64 Quick Ratio3.38Price-To-Earnings Trailing P/E RatioN/A Forward P/E Ratio115.60 P/E GrowthN/A Sales & Book Value Annual SalesC$35.22 million Price / Sales17.34 Cash FlowN/A Price / Cash FlowN/A Book ValueC$1.35 per share Price / Book4.28Profitability EPS (Most Recent Fiscal Year)C($0.11) Net IncomeC$-10,460,000.00 Net Margins-22.33% Return on Equity-6.69% Return on Assets-5.71%Miscellaneous Employees576 Outstanding Shares105,639,000Market CapC$610.59 million Next Earnings Date8/13/2019 (Estimated) OptionableOptionable CannTrust (NYSE:CTST) Frequently Asked Questions What is CannTrust's stock symbol? CannTrust trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTST." How were CannTrust's earnings last quarter? CannTrust Holdings Inc (NYSE:CTST) announced its earnings results on Tuesday, May, 14th. The company reported $0.09 EPS for the quarter, beating analysts' consensus estimates of ($0.05) by $0.14. The business earned $16.85 million during the quarter, compared to analysts' expectations of $17 million. CannTrust had a negative return on equity of 6.69% and a negative net margin of 22.33%. The business's revenue was up 114.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.12 earnings per share. View CannTrust's Earnings History. When is CannTrust's next earnings date? CannTrust is scheduled to release their next quarterly earnings announcement on Tuesday, August 13th 2019. View Earnings Estimates for CannTrust. What guidance has CannTrust issued on next quarter's earnings? CannTrust updated its first quarter 2019 earnings guidance on Monday, April, 22nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $17-17 million. What price target have analysts set for CTST? 2 brokers have issued twelve-month target prices for CannTrust's shares. Their forecasts range from C$5.69 to C$14.50. On average, they anticipate CannTrust's stock price to reach C$10.10 in the next twelve months. This suggests a possible upside of 73.9% from the stock's current price. View Analyst Price Targets for CannTrust. What is the consensus analysts' recommendation for CannTrust? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CannTrust in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CannTrust. Has CannTrust been receiving favorable news coverage? News headlines about CTST stock have trended somewhat positive this week, InfoTrie Sentiment reports. The research group rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. CannTrust earned a media sentiment score of 1.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the near term. Are investors shorting CannTrust? CannTrust saw a increase in short interest in April. As of April 15th, there was short interest totalling 3,363,856 shares, an increase of 41.7% from the March 29th total of 2,374,612 shares. Based on an average trading volume of 1,834,704 shares, the short-interest ratio is currently 1.8 days. View CannTrust's Current Options Chain. Who are some of CannTrust's key competitors? Some companies that are related to CannTrust include Amneal Pharmaceuticals (AMRX), Uniqure (QURE), PTC Therapeutics (PTCT), Myokardia (MYOK), Emergent Biosolutions (EBS), Ligand Pharmaceuticals (LGND), Arrowhead Pharmaceuticals (ARWR), Insmed (INSM), AnaptysBio (ANAB), Portola Pharmaceuticals (PTLA), Akcea Therapeutics (AKCA), Endocyte (ECYT), Allakos (ALLK), Tricida (TCDA) and Xencor (XNCR). What other stocks do shareholders of CannTrust own? Based on aggregate information from My MarketBeat watchlists, some companies that other CannTrust investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), KushCo (KSHB), Aurora Cannabis (ACB), Aphria (APHA), Cronos Group (CRON), Canopy Growth (WEED), Aphria (APHA), Surna (SRNA) and OrganiGram (OGRMF). Who are CannTrust's key executives? CannTrust's management team includes the folowing people: Mr. Eric Paul, Co-Founder & Chairman (Age 78)Mr. Brad Rogers, Pres (Age 49)Mr. Ian Abramowitz, Sr. VP of Global Investments & Partnerships (Age 64)Mr. Peter Ralph Aceto, Chief Exec. OfficerMr. Greg Guyatt, Chief Financial Officer Who are CannTrust's major shareholders? CannTrust's stock is owned by many different of institutional and retail investors. Top institutional investors include The Manufacturers Life Insurance Company (1.45%), JW Asset Management LLC (1.33%), Morgan Stanley (1.02%), Davis Rea LTD. (0.47%), Toronto Dominion Bank (0.25%) and Legacy Advisors LLC (0.19%). Company insiders that own CannTrust stock include Aubrey Dan, Financial Corporation Forum, Mark Litwin and Mitchell J Sanders. View Institutional Ownership Trends for CannTrust. Which institutional investors are buying CannTrust stock? CTST stock was purchased by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company , JW Asset Management LLC, Morgan Stanley, Davis Rea LTD., Toronto Dominion Bank, Legacy Advisors LLC, CIBC Asset Management Inc and BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp. View Insider Buying and Selling for CannTrust. How do I buy shares of CannTrust? Shares of CTST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is CannTrust's stock price today? One share of CTST stock can currently be purchased for approximately C$5.81. How big of a company is CannTrust? CannTrust has a market capitalization of C$613.33 million and generates C$35.22 million in revenue each year. The company earns C$-10,460,000.00 in net income (profit) each year or C($0.11) on an earnings per share basis. CannTrust employs 576 workers across the globe. What is CannTrust's official website? The official website for CannTrust is http://canntrust.ca/. How can I contact CannTrust? CannTrust's mailing address is 3280 Langstaff Road Building 1, Vaughan A6, L4K 5B6. The company can be reached via phone at 64-7872-2300 or via email at [email protected] MarketBeat Community Rating for CannTrust (NYSE CTST)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 104 (Vote Outperform)Underperform Votes: 114 (Vote Underperform)Total Votes: 218MarketBeat's community ratings are surveys of what our community members think about CannTrust and other stocks. Vote "Outperform" if you believe CTST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CTST will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/24/2019 by MarketBeat.com StaffFeatured Article: Penny Stocks, Risk and Reward Factors Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.